The frequencies of TAA-specific CD8+ T cells were comparable in HCC patients and in healthy donors (HD) or in patients with liver cirrhosis but lower compared to virus-specific CD8+ T cells present in HCC patients. The gene discussed is CD8A; the disease is hepatocellular carcinoma.